The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
IVIG-Global Market Insights and Sales Trends 2025
Synopsis
The global IVIG market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of IVIG in various end use industries. The expanding demands from the Multiple Sclerosis(MS), Myasthenia Gravis(MG), Multifocal Motor Neuropathy(MMN) and Multifocal Acquired Sensory and Motor Neuropathy(MADSAM), are propelling IVIG market. Injection IVIG, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lyophilized Powder IVIG segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for IVIG market, driven by demand from China, the second largest economy with some signs of stabilising, the IVIG market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for IVIG, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global IVIG market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global IVIG market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, IVIG sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of IVIG covered in this report include Green Cross, BSV, Hualan Bio, RAAS, YUAN DA SHUYANG, Kangbao Bio, Tiantan Bio, Taibang Bio and Weiguang Bio, etc.
The global IVIG market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Green Cross
BSV
Hualan Bio
RAAS
YUAN DA SHUYANG
Kangbao Bio
Tiantan Bio
Taibang Bio
Weiguang Bio
SIBP
TONROL
RUIDE Bio
BOYA Bio
RUIDE Bio
Xinxing Medicine
Weilun Bio
WIBP
Global IVIG market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global IVIG market, Segment by Type:
Injection IVIG
Lyophilized Powder IVIG
Global IVIG market, by Application
Multiple Sclerosis(MS)
Myasthenia Gravis(MG)
Multifocal Motor Neuropathy(MMN)
Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
Dermatomyositis
Polymyositis
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of IVIG manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of IVIG in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global IVIG market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of IVIG in various end use industries. The expanding demands from the Multiple Sclerosis(MS), Myasthenia Gravis(MG), Multifocal Motor Neuropathy(MMN) and Multifocal Acquired Sensory and Motor Neuropathy(MADSAM), are propelling IVIG market. Injection IVIG, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lyophilized Powder IVIG segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for IVIG market, driven by demand from China, the second largest economy with some signs of stabilising, the IVIG market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for IVIG, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global IVIG market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global IVIG market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, IVIG sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of IVIG covered in this report include Green Cross, BSV, Hualan Bio, RAAS, YUAN DA SHUYANG, Kangbao Bio, Tiantan Bio, Taibang Bio and Weiguang Bio, etc.
The global IVIG market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Green Cross
BSV
Hualan Bio
RAAS
YUAN DA SHUYANG
Kangbao Bio
Tiantan Bio
Taibang Bio
Weiguang Bio
SIBP
TONROL
RUIDE Bio
BOYA Bio
RUIDE Bio
Xinxing Medicine
Weilun Bio
WIBP
Global IVIG market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global IVIG market, Segment by Type:
Injection IVIG
Lyophilized Powder IVIG
Global IVIG market, by Application
Multiple Sclerosis(MS)
Myasthenia Gravis(MG)
Multifocal Motor Neuropathy(MMN)
Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
Dermatomyositis
Polymyositis
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of IVIG manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of IVIG in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 IVIG Market Overview
1.1 IVIG Product Overview
1.2 IVIG Market Segment by Type
1.2.1 Injection IVIG
1.2.2 Lyophilized Powder IVIG
1.3 Global IVIG Market Size by Type
1.3.1 Global IVIG Market Size Overview by Type (2018-2029)
1.3.2 Global IVIG Historic Market Size Review by Type (2018-2023)
1.3.3 Global IVIG Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America IVIG Sales Breakdown by Type (2018-2023)
1.4.2 Europe IVIG Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific IVIG Sales Breakdown by Type (2018-2023)
1.4.4 Latin America IVIG Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa IVIG Sales Breakdown by Type (2018-2023)
2 Global IVIG Market Competition by Company
2.1 Global Top Players by IVIG Sales (2018-2023)
2.2 Global Top Players by IVIG Revenue (2018-2023)
2.3 Global Top Players by IVIG Price (2018-2023)
2.4 Global Top Manufacturers IVIG Manufacturing Base Distribution, Sales Area, Product Type
2.5 IVIG Market Competitive Situation and Trends
2.5.1 IVIG Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by IVIG Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in IVIG as of 2022)
2.7 Date of Key Manufacturers Enter into IVIG Market
2.8 Key Manufacturers IVIG Product Offered
2.9 Mergers & Acquisitions, Expansion
3 IVIG Status and Outlook by Region
3.1 Global IVIG Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global IVIG Historic Market Size by Region
3.2.1 Global IVIG Sales in Volume by Region (2018-2023)
3.2.2 Global IVIG Sales in Value by Region (2018-2023)
3.2.3 Global IVIG Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global IVIG Forecasted Market Size by Region
3.3.1 Global IVIG Sales in Volume by Region (2024-2029)
3.3.2 Global IVIG Sales in Value by Region (2024-2029)
3.3.3 Global IVIG Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global IVIG by Application
4.1 IVIG Market Segment by Application
4.1.1 Multiple Sclerosis(MS)
4.1.2 Myasthenia Gravis(MG)
4.1.3 Multifocal Motor Neuropathy(MMN)
4.1.4 Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
4.1.5 Dermatomyositis
4.1.6 Polymyositis
4.2 Global IVIG Market Size by Application
4.2.1 Global IVIG Market Size Overview by Application (2018-2029)
4.2.2 Global IVIG Historic Market Size Review by Application (2018-2023)
4.2.3 Global IVIG Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America IVIG Sales Breakdown by Application (2018-2023)
4.3.2 Europe IVIG Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific IVIG Sales Breakdown by Application (2018-2023)
4.3.4 Latin America IVIG Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa IVIG Sales Breakdown by Application (2018-2023)
5 North America IVIG by Country
5.1 North America IVIG Historic Market Size by Country
5.1.1 North America IVIG Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America IVIG Sales in Volume by Country (2018-2023)
5.1.3 North America IVIG Sales in Value by Country (2018-2023)
5.2 North America IVIG Forecasted Market Size by Country
5.2.1 North America IVIG Sales in Volume by Country (2024-2029)
5.2.2 North America IVIG Sales in Value by Country (2024-2029)
6 Europe IVIG by Country
6.1 Europe IVIG Historic Market Size by Country
6.1.1 Europe IVIG Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe IVIG Sales in Volume by Country (2018-2023)
6.1.3 Europe IVIG Sales in Value by Country (2018-2023)
6.2 Europe IVIG Forecasted Market Size by Country
6.2.1 Europe IVIG Sales in Volume by Country (2024-2029)
6.2.2 Europe IVIG Sales in Value by Country (2024-2029)
7 Asia-Pacific IVIG by Region
7.1 Asia-Pacific IVIG Historic Market Size by Region
7.1.1 Asia-Pacific IVIG Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific IVIG Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific IVIG Sales in Value by Region (2018-2023)
7.2 Asia-Pacific IVIG Forecasted Market Size by Region
7.2.1 Asia-Pacific IVIG Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific IVIG Sales in Value by Region (2024-2029)
8 Latin America IVIG by Country
8.1 Latin America IVIG Historic Market Size by Country
8.1.1 Latin America IVIG Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America IVIG Sales in Volume by Country (2018-2023)
8.1.3 Latin America IVIG Sales in Value by Country (2018-2023)
8.2 Latin America IVIG Forecasted Market Size by Country
8.2.1 Latin America IVIG Sales in Volume by Country (2024-2029)
8.2.2 Latin America IVIG Sales in Value by Country (2024-2029)
9 Middle East and Africa IVIG by Country
9.1 Middle East and Africa IVIG Historic Market Size by Country
9.1.1 Middle East and Africa IVIG Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa IVIG Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa IVIG Sales in Value by Country (2018-2023)
9.2 Middle East and Africa IVIG Forecasted Market Size by Country
9.2.1 Middle East and Africa IVIG Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa IVIG Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Green Cross
10.1.1 Green Cross Company Information
10.1.2 Green Cross Introduction and Business Overview
10.1.3 Green Cross IVIG Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Green Cross IVIG Products Offered
10.1.5 Green Cross Recent Development
10.2 BSV
10.2.1 BSV Company Information
10.2.2 BSV Introduction and Business Overview
10.2.3 BSV IVIG Sales, Revenue and Gross Margin (2018-2023)
10.2.4 BSV IVIG Products Offered
10.2.5 BSV Recent Development
10.3 Hualan Bio
10.3.1 Hualan Bio Company Information
10.3.2 Hualan Bio Introduction and Business Overview
10.3.3 Hualan Bio IVIG Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Hualan Bio IVIG Products Offered
10.3.5 Hualan Bio Recent Development
10.4 RAAS
10.4.1 RAAS Company Information
10.4.2 RAAS Introduction and Business Overview
10.4.3 RAAS IVIG Sales, Revenue and Gross Margin (2018-2023)
10.4.4 RAAS IVIG Products Offered
10.4.5 RAAS Recent Development
10.5 YUAN DA SHUYANG
10.5.1 YUAN DA SHUYANG Company Information
10.5.2 YUAN DA SHUYANG Introduction and Business Overview
10.5.3 YUAN DA SHUYANG IVIG Sales, Revenue and Gross Margin (2018-2023)
10.5.4 YUAN DA SHUYANG IVIG Products Offered
10.5.5 YUAN DA SHUYANG Recent Development
10.6 Kangbao Bio
10.6.1 Kangbao Bio Company Information
10.6.2 Kangbao Bio Introduction and Business Overview
10.6.3 Kangbao Bio IVIG Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Kangbao Bio IVIG Products Offered
10.6.5 Kangbao Bio Recent Development
10.7 Tiantan Bio
10.7.1 Tiantan Bio Company Information
10.7.2 Tiantan Bio Introduction and Business Overview
10.7.3 Tiantan Bio IVIG Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Tiantan Bio IVIG Products Offered
10.7.5 Tiantan Bio Recent Development
10.8 Taibang Bio
10.8.1 Taibang Bio Company Information
10.8.2 Taibang Bio Introduction and Business Overview
10.8.3 Taibang Bio IVIG Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Taibang Bio IVIG Products Offered
10.8.5 Taibang Bio Recent Development
10.9 Weiguang Bio
10.9.1 Weiguang Bio Company Information
10.9.2 Weiguang Bio Introduction and Business Overview
10.9.3 Weiguang Bio IVIG Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Weiguang Bio IVIG Products Offered
10.9.5 Weiguang Bio Recent Development
10.10 SIBP
10.10.1 SIBP Company Information
10.10.2 SIBP Introduction and Business Overview
10.10.3 SIBP IVIG Sales, Revenue and Gross Margin (2018-2023)
10.10.4 SIBP IVIG Products Offered
10.10.5 SIBP Recent Development
10.11 TONROL
10.11.1 TONROL Company Information
10.11.2 TONROL Introduction and Business Overview
10.11.3 TONROL IVIG Sales, Revenue and Gross Margin (2018-2023)
10.11.4 TONROL IVIG Products Offered
10.11.5 TONROL Recent Development
10.12 RUIDE Bio
10.12.1 RUIDE Bio Company Information
10.12.2 RUIDE Bio Introduction and Business Overview
10.12.3 RUIDE Bio IVIG Sales, Revenue and Gross Margin (2018-2023)
10.12.4 RUIDE Bio IVIG Products Offered
10.12.5 RUIDE Bio Recent Development
10.13 BOYA Bio
10.13.1 BOYA Bio Company Information
10.13.2 BOYA Bio Introduction and Business Overview
10.13.3 BOYA Bio IVIG Sales, Revenue and Gross Margin (2018-2023)
10.13.4 BOYA Bio IVIG Products Offered
10.13.5 BOYA Bio Recent Development
10.14 RUIDE Bio
10.14.1 RUIDE Bio Company Information
10.14.2 RUIDE Bio Introduction and Business Overview
10.14.3 RUIDE Bio IVIG Sales, Revenue and Gross Margin (2018-2023)
10.14.4 RUIDE Bio IVIG Products Offered
10.14.5 RUIDE Bio Recent Development
10.15 Xinxing Medicine
10.15.1 Xinxing Medicine Company Information
10.15.2 Xinxing Medicine Introduction and Business Overview
10.15.3 Xinxing Medicine IVIG Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Xinxing Medicine IVIG Products Offered
10.15.5 Xinxing Medicine Recent Development
10.16 Weilun Bio
10.16.1 Weilun Bio Company Information
10.16.2 Weilun Bio Introduction and Business Overview
10.16.3 Weilun Bio IVIG Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Weilun Bio IVIG Products Offered
10.16.5 Weilun Bio Recent Development
10.17 WIBP
10.17.1 WIBP Company Information
10.17.2 WIBP Introduction and Business Overview
10.17.3 WIBP IVIG Sales, Revenue and Gross Margin (2018-2023)
10.17.4 WIBP IVIG Products Offered
10.17.5 WIBP Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 IVIG Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 IVIG Industrial Chain Analysis
11.4 IVIG Market Dynamics
11.4.1 IVIG Industry Trends
11.4.2 IVIG Market Drivers
11.4.3 IVIG Market Challenges
11.4.4 IVIG Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 IVIG Distributors
12.3 IVIG Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
